A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is
Trends in Nanocarrier based Delivery Systems of Methotrexate: Update 2020
Cancer Science & Research
Methotrexate is commonly used as anticancer and anti-inflammatory agent to cure various types of cancerous and auto-immune disorders. An optimum dose of MXT is proven to inhibit the di-hydro-folate-reductase that obstruct the purine multiplication. The nanotechnology-based carriers have outranged in since decade and fabricated as multifunctional complexes to cater medicinal agents for biomedical and pharmaceutical applications. The present review aims on upbringing the understanding the variousdoi:10.33425/2639-8478.1064 fatcat:7xudtbvwzrh2tbgrv5otmlsykm